Last Updated: November 12, 2026

SOLUPREP S Drug Patent Profile

Name: SOLUPREP S Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Soluprep S patents expire, and what generic alternatives are available?

Soluprep S is a drug marketed by Solventum and is included in one NDA.

The generic ingredient in SOLUPREP S is chlorhexidine gluconate; isopropyl alcohol. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for SOLUPREP S?
What are the global sales for SOLUPREP S?
What is Average Wholesale Price for SOLUPREP S?

Summary for SOLUPREP S

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Clinical Trials:	4
DailyMed Link:	SOLUPREP S at DailyMed

Drug patent expirations by year for SOLUPREP S

Recent Clinical Trials for SOLUPREP S

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal	Phase 4
Claire Bourgeois	Phase 4
Fédération des médecins résidents du Québec	Phase 4

See all SOLUPREP S clinical trials

Pharmacology for SOLUPREP S

Physiological Effect	Decreased Cell Wall Integrity

US Patents and Regulatory Information for SOLUPREP S

SOLUPREP S is protected by zero US patents and one FDA Regulatory Exclusivity.

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Solventum	SOLUPREP S	chlorhexidine gluconate; isopropyl alcohol	SOLUTION;TOPICAL	208288-001	Aug 8, 2018		OTC	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for SOLUPREP S

See the table below for patents covering SOLUPREP S around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Australia	2008347253	Antimicrobial compositions	⤷ Start Trial
Brazil	PI0819567	"composições antimicrobianas, método para aprimorar a adesão molhada do artigo adesivo médico e método para evitar ou tratar uma condição da pele de um mamífero	⤷ Start Trial
Canada	2711217	COMPOSITIONS ANTIMICROBIENNES (ANTIMICROBIAL COMPOSITIONS)	⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.